U.S. lawmakers held a hearing Thursday to discuss a House draft bill that would require the tracking of medicines by lots, instead of tracing every drug unit as proposed in a Senate bill and favored by the FDA. Independent pharmacists argue requirements that they maintain or access an electronic pedigree when dispensing drugs would be burdensome, but strong national standards are essential to fight counterfeit medicines, according to Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.

Full Story:
Politico, Reuters

Related Summaries